Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Government Mechanics

Federal Register

The federal government's official daily journal where every proposed and final rule, notice, and order is published.

Also known as: The Register, FR

What it is
The Federal Register is the daily publication of the U.S. government that records proposed rules, final rules, executive orders, and agency notices. It is the legal system of record for regulatory action. Rules generally are not enforceable until published there.
What it does
It is the primary source for spotting regulatory catalysts before mainstream coverage. A proposed rule opens a comment window that telegraphs a coming change; a final rule sets the effective date. Investors mine it for tariff notices, FDA actions, and agency approvals that move specific tickers.
The evidence
Tariff schedules, EPA emissions rules, and FDA orders all appear here first, often before the price move fully materializes in affected stocks.
Best for
Any regulated sector; especially XLU, XLE, XLV, and industrial names exposed to new standards.
Pairs well with
executive-order, tariff, fda-approval
Use cautiously with
A proposed rule is not final; treating a comment-stage notice as a done deal can whipsaw you when the final rule is softened or delayed.
Cautions
Effective dates can be months out, so a published rule may be a slow-burn catalyst rather than a same-day trade.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo